300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
SaaS
Cryptocurrency
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Blockchain
Facebook
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Theatre
Medical
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Burkina Faso
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Botswana
Ireland
Paraguay
Japan
South Africa
France
Canada
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
United Kingdom
Malaysia
Portugal
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Philippines
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Argentina
Angola
Europe
Cyprus
Bangladesh
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Slovenia
Mongolia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Sparkasse Jena, VC Fund

Sparkasse Jena

VC Fund

Jena, Germany

Sparkasse Jena is a German savings bank offers a collection of financial products and services to private, retail, and corporate customers.

Total investments:
7
Last investment:
Lead investor:
29%

Last updated:

Industries Sparkasse Jena invests in

MedicalHealth CareShoppingE-CommerceBiotechnology

Stages Sparkasse Jena invests in

SeedSeries ASeries C

Countries Sparkasse Jena invests in

GermanyUnited States

Investment Focus

Industry

  • Medical 3 (43%)
  • Health Care 3 (43%)
  • Shopping 2 (29%)
  • E-Commerce 2 (29%)
  • Biotechnology 2 (29%)
See all 16 industries →

Stage

  • Seed 4 (57%)
  • Series A 2 (29%)
  • Series C 1 (14%)

Country

  • Germany 6 (86%)
  • United States 1 (14%)

Investments

CompanyDescriptionRoundLinks
PERCEPTEC PERCEPTEC
PERCEPTEC is an application-oriented think tank with the aim of accelerating the process of modernization and digitalization of the optometric and ophthalmological sector. Seed / Jun 30, 2025
DeepEn DeepEn
DeepEn is a research transfer start-up from Leibniz Institute of Photonic Technologies. It focus on the development of solutions in the field of fibrephotonics, biophotonics and bioimaging. Seed / Feb 17, 2025
NovaPump NovaPump
The NovaPump GmbH is a cardiology company based in Jena/Germany devoloping cutting-edge therapeutical solutions in the field of non-invasive and percutaneous circulation support. The so called PERKAT (PERKutane KATheterpumpe) technique will be offered as pLVAD & pRVAD heart pumps for acute left or right heart patients within the nextyears. PERKAT works together with the current IABP technique (intra aortic balloon pump with about 200,000 cases p.a. internationally) and is the only-one catheter-based & self-expanding, pulsatile & ECG-triggered, cost-effective heart pump technique with a high pump performance. PERKAT is not available on the market so far. Articles in leading scientific journals and presentations at the top four international cardiology conferences in the last years show the medical need, the development status and the technological and medical advantages of PERKAT. Series A / Jun 05, 2020
Dynamic42 Dynamic42
Dy­nam­ic42 provides, customizes innovative 3D mi­cro­phys­i­o­log­i­cal in vit­ro test systems recre­at­ing human organ key functions. It develops and markets novel, three-dimensional, human organ models (scalloped organ-on-chip technology) for pre­clin­i­cal research and developmental, as well as for testing novel pharmaceutical products,chemicals, and food additives. It is specialized in the area of organ-on-chip technology in the integration of the immune system, which plays a significant role in the occurrence of adverse effects of drugs and has been neglected in the industry and in two-dimensional test systems. Seed / Apr 06, 2020
ShopCo Technologies ShopCo Technologies
Shop uses Artificial Intelligence to empower online shopping experience for customers. It is a universal shopping cart browser extension that keeps all the items of its users across the web in one spot. Stores can be registered online and without any hassle. It helps its users browse through a wide range of online stores and checkout from one spot.The company gives ability to connect to all its users existing retailer accounts. It also secures data with encryption methods and two-step verifications. Shop is a U.S.-based company that was founded in 2014 by Jay Habib. $7M / Seed / Feb 03, 2017
oncgnostics GmbH oncgnostics GmbH
oncgnostics develops - based on proprietary epigenetic biomarkers - highly reliable in vitro diagnostic (=IVD) tests for screening, therapeutic decisions and follow-up care in cancer diagnostics.The diagnostic tests developed by oncgnostics are based on DNA regions specifically methylated in precancerous and carcinoma cells. These markerregions are detected using well-established PCR-based technologies, which can be performed in routine molecular diagnostics laboratories with standard equipment. oncgnostics has identified novel markers for detecting cervical precancerous lesions and carcinomas. Series A / Jan 29, 2015
Preisbock Preisbock
Preisbock.de is a “Live Shop” on the internet that each day offers a greatly reduced product for spontaneous sale as “deal of the day”. The offer is valid for up to a week as long as stocks last. The business model is based on cooperation with established retailers and manufacturers. Preisbock.de was founded in July 2007 by dotSource GmbH.Since the beginning of 2008 the portal has been part of Preisbock GmbH, comprising marketing and sales experts who can call on many years of experience in E-commerce. $1.1M / Series C / Feb 09, 2009

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
SaaS
Cryptocurrency
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Blockchain
Facebook
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Theatre
Medical
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Burkina Faso
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Botswana
Ireland
Paraguay
Japan
South Africa
France
Canada
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
United Kingdom
Malaysia
Portugal
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Philippines
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Argentina
Angola
Europe
Cyprus
Bangladesh
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Slovenia
Mongolia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Sparkasse Jena invest in?

Sparkasse Jena invests primarily in Medical, Health Care and Shopping startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Sparkasse Jena last invest?

The most recent investment recorded for Sparkasse Jena closed in Jun 2025. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Sparkasse Jena Sparkasse Jena Find emails